A Study of Telitacicept in Patients With Ocular Myasthenia Gravis (OMG) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Study of Telitacicept in Patients With Ocular Myasthenia Gravis (OMG) — Stella

Recruiting

Back to Myasthenia Gravis, Ocular trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

China

Beijing Hospital, Beijing, Beijing Municipality

Key details

Phase

Large-scale testing

Sponsor

RemeGen Co., Ltd.

Collaborators

Huashan Hospital, Beijing Hospital

Enrollment target

~120 participants

Started

January 2026

Primary completion

December 2026

Age range

12 Years – 80 Years

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov